{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:06:37Z","timestamp":1792004797609,"version":"4.4.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T00:00:00Z","timestamp":1529971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1,18]]},"DOI":"10.1093\/cid\/ciy514","type":"journal-article","created":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T19:14:26Z","timestamp":1529954066000},"page":"466-474","source":"Crossref","is-referenced-by-count":26,"title":["The Candidate Blood-stage Malaria Vaccine P27A Induces a Robust Humoral Response in a Fast Track to the Field Phase 1 Trial in Exposed and Nonexposed Volunteers"],"prefix":"10.1093","volume":"68","author":[{"given":"Viviane","family":"Steiner-Monard","sequence":"first","affiliation":[{"name":"Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kassim","family":"Kamaka","sequence":"additional","affiliation":[{"name":"Ifakara Health Institute, Bagamoyo, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olfa","family":"Karoui","sequence":"additional","affiliation":[{"name":"Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Roethlisberger","sequence":"additional","affiliation":[{"name":"Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gine","family":"Audran","sequence":"additional","affiliation":[{"name":"Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Daubenberger","sequence":"additional","affiliation":[{"name":"Swiss Tropical and Public Health Institute, Basel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Fayet-Mello","sequence":"additional","affiliation":[{"name":"Clinical Trial Unit, CHUV, Lausanne"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Erdmann-Voisin","sequence":"additional","affiliation":[{"name":"Clinical Trial Unit, CHUV, Lausanne"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Felger","sequence":"additional","affiliation":[{"name":"Swiss Tropical and Public Health Institute, Basel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Geiger","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Lausanne, Epalinges, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lerisa","family":"Govender","sequence":"additional","affiliation":[{"name":"Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Houard","sequence":"additional","affiliation":[{"name":"European Vaccine Initiative, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Huber","sequence":"additional","affiliation":[{"name":"Swiss Tropical and Public Health Institute, Basel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Mayor","sequence":"additional","affiliation":[{"name":"Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Mkindi","sequence":"additional","affiliation":[{"name":"Swiss Tropical and Public Health Institute, Basel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Portevin","sequence":"additional","affiliation":[{"name":"Swiss Tropical and Public Health Institute, Basel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Rusch","sequence":"additional","affiliation":[{"name":"Swiss Tropical and Public Health Institute, Basel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Schmidlin","sequence":"additional","affiliation":[{"name":"Swiss Tropical and Public Health Institute, Basel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regis W","family":"Tiendrebeogo","sequence":"additional","affiliation":[{"name":"Department for Congenital Disorders, Statens Serum Institut, Denmark"},{"name":"Centre for Medical Parasitology, University of Copenhagen, Denmark"},{"name":"Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Theisen","sequence":"additional","affiliation":[{"name":"Department for Congenital Disorders, Statens Serum Institut, Denmark"},{"name":"Centre for Medical Parasitology, University of Copenhagen, Denmark"},{"name":"Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Christine","family":"Thierry","sequence":"additional","affiliation":[{"name":"Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Vallotton","sequence":"additional","affiliation":[{"name":"Clinical Trial Unit, CHUV, Lausanne"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampietro","family":"Corradin","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Lausanne, Epalinges, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Leroy","sequence":"additional","affiliation":[{"name":"European Vaccine Initiative, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Abdulla","sequence":"additional","affiliation":[{"name":"Ifakara Health Institute, Bagamoyo, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seif","family":"Shekalaghe","sequence":"additional","affiliation":[{"name":"Ifakara Health Institute, Bagamoyo, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blaise","family":"Genton","sequence":"additional","affiliation":[{"name":"Swiss Tropical and Public Health Institute, Basel"},{"name":"Policlinique m\u00e9dicale universitaire, Lausanne, Switzerland"},{"name":"Infectious Disease Service, CHUV, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Spertini","sequence":"additional","affiliation":[{"name":"Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said A","family":"Jongo","sequence":"additional","affiliation":[{"name":"Ifakara Health Institute, Bagamoyo, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,6,26]]},"reference":[{"key":"key\n\t\t\t\t2019011723582674600_CIT0001","first-page":"2362","article-title":"Analysis of the immunogenicity and bioactivities of a split influenza A\/H7N9 vaccine mixed with MF59 adjuvant in BALB\/c mice","volume":"34","author":"Ou","year":"2016","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019011723582674600_CIT0002","first-page":"733","article-title":"Gamma-globulin and acquired immunity to human malaria","volume":"192","author":"Cohen","year":"1961","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019011723582674600_CIT0003","first-page":"297","article-title":"Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria","volume":"45","author":"Sabchareon","year":"1991","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t2019011723582674600_CIT0004","first-page":"208","article-title":"Molecular mechanisms that mediate invasion and egress of malaria parasites from red blood cells","volume":"24","author":"Alaganan","year":"2017","journal-title":"Curr Opin Hematol"},{"key":"key\n\t\t\t\t2019011723582674600_CIT0005","first-page":"887","article-title":"Functional antibodies and protection against blood-stage malaria","volume":"32","author":"Teo","year":"2016","journal-title":"Trends Parasitol"},{"key":"key\n\t\t\t\t2019011723582674600_CIT0006","first-page":"e645","article-title":"Rapid identification of malaria vaccine candidates based on alpha-helical coiled coil protein motif","volume":"2","author":"Villard","year":"2007","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019011723582674600_CIT0007","first-page":"e46112","article-title":"Cell biological characterization of the malaria vaccine candidate trophozoite exported protein 1","volume":"7","author":"Kulangara","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019011723582674600_CIT0008","first-page":"5701","article-title":"Vaccine potentials of an intrinsically unstructured fragment derived from the blood stage-associated Plasmodium falciparum protein PFF0165c","volume":"77","author":"Olugbile","year":"2009","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t2019011723582674600_CIT0009","first-page":"409","article-title":"Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages","volume":"182","author":"Bouharoun-Tayoun","year":"1995","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t2019011723582674600_CIT0010","first-page":"31","article-title":"Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial","volume":"386","author":"RTS,S","year":"2015","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019011723582674600_CIT0011","first-page":"287","article-title":"Safety and immunogenicity of the novel tuberculosis vaccine ID93\u2008+\u2008GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial","volume":"6","author":"Penn-Nicholson","year":"2018","journal-title":"Lancet Respir Med"},{"key":"key\n\t\t\t\t2019011723582674600_CIT0012","first-page":"6218","article-title":"Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel in European and African adults: a phase 1a\/1b, randomized, double-blind multi-centre trial","volume":"35","author":"Sirima","year":"2017","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019011723582674600_CIT0013","first-page":"477","article-title":"Advances in aluminum hydroxide-based adjuvant research and its mechanism","volume":"11","author":"He","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"key\n\t\t\t\t2019011723582674600_CIT0014","first-page":"e35","article-title":"From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE","volume":"4","author":"Coler","year":"2015","journal-title":"Clin Transl Immunology"},{"key":"key\n\t\t\t\t2019011723582674600_CIT0015","first-page":"7621","article-title":"Reduced antibody responses against Plasmodium falciparum vaccine candidate antigens in the presence of Trichuris trichiura","volume":"30","author":"Esen","year":"2012","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019011723582674600_CIT0016","first-page":"666","article-title":"Regulation of the host immune system by helminth parasites","volume":"138","author":"Maizels","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"key\n\t\t\t\t2019011723582674600_CIT0017","first-page":"e10685","article-title":"Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model","volume":"5","author":"Guilbride","year":"2010","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019011723582674600_CIT0018","first-page":"ofv044","article-title":"Antibody-dependent cellular inhibition is associated with reduced risk against febrile malaria in a longitudinal cohort study involving Ghanaian children","volume":"2","author":"Tiendrebeogo","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"key\n\t\t\t\t2019011723582674600_CIT0019","first-page":"8017","article-title":"Phase I malaria vaccine trial with a long synthetic peptide derived from the merozoite surface protein 3 antigen","volume":"73","author":"Audran","year":"2005","journal-title":"Infect Immun"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/68\/3\/466\/27512554\/ciy514.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T04:58:39Z","timestamp":1547787519000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/68\/3\/466\/5045203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,26]]},"references-count":19,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,6,26]]},"published-print":{"date-parts":[[2019,1,18]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy514","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2,1]]},"published":{"date-parts":[[2018,6,26]]}}}